DK1385492T3 - Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis - Google Patents

Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis

Info

Publication number
DK1385492T3
DK1385492T3 DK01987663T DK01987663T DK1385492T3 DK 1385492 T3 DK1385492 T3 DK 1385492T3 DK 01987663 T DK01987663 T DK 01987663T DK 01987663 T DK01987663 T DK 01987663T DK 1385492 T3 DK1385492 T3 DK 1385492T3
Authority
DK
Denmark
Prior art keywords
hyaluronic acid
acid derivatives
inflammatory arthritis
inhibit inflammatory
arthritis
Prior art date
Application number
DK01987663T
Other languages
Danish (da)
English (en)
Inventor
Rudolf Venbrocks
Andreas Roth
Peter-Juergen Mueller
Stephanie Moeller
Joerg Ozegowski
Gundela Peschel
Original Assignee
Wpmo Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1385492(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wpmo Gmbh filed Critical Wpmo Gmbh
Application granted granted Critical
Publication of DK1385492T3 publication Critical patent/DK1385492T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DK01987663T 2000-10-19 2001-10-19 Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis DK1385492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10053053A DE10053053A1 (de) 2000-10-19 2000-10-19 Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
PCT/DE2001/003984 WO2002032407A2 (de) 2000-10-19 2001-10-19 Verwendung von hyaluronsäure-derivaten zur hemmung von entzündlichen arthritiden

Publications (1)

Publication Number Publication Date
DK1385492T3 true DK1385492T3 (da) 2007-07-30

Family

ID=7661103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01987663T DK1385492T3 (da) 2000-10-19 2001-10-19 Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis

Country Status (13)

Country Link
US (2) US20040053885A1 (ja)
EP (1) EP1385492B1 (ja)
JP (1) JP2004531460A (ja)
AT (1) ATE357224T1 (ja)
AU (2) AU2152802A (ja)
CA (1) CA2426083A1 (ja)
CY (1) CY1106479T1 (ja)
DE (2) DE10053053A1 (ja)
DK (1) DK1385492T3 (ja)
ES (1) ES2284714T3 (ja)
HK (1) HK1062524A1 (ja)
PT (1) PT1385492E (ja)
WO (1) WO2002032407A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111165A1 (de) * 2001-03-02 2002-10-10 Knoell Hans Forschung Ev Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen
JP2005239687A (ja) * 2004-02-27 2005-09-08 Nobuhiko Yui 嚢胞内投与薬
EP1768685B1 (en) * 2004-06-30 2015-01-14 E-L Management Corp. Cosmetic compositions and methods comprising rhodiola rosea
JP2007275388A (ja) * 2006-04-10 2007-10-25 Toshie Tsuchiya 細胞の分化を促進し、かつ炎症を抑制する人工器官
ITPD20060219A1 (it) 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
JP5088864B2 (ja) * 2007-03-16 2012-12-05 オリンパス株式会社 生体組織補填材とその製造方法
US10028976B2 (en) * 2007-07-02 2018-07-24 Aptissen Sa Injectable formulation of natural polysaccharide and polyol for treatment of osteoarthritis
PL2252290T3 (pl) * 2008-02-15 2018-06-29 Bone Therapeutics S.A. Kompozycja farmaceutyczna do zastosowania w leczeniu i/lub zapobieganiu chorobom kostno-stawowym
AU2009231634B2 (en) * 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
IT1393945B1 (it) 2009-04-21 2012-05-17 Fidia Farmaceutici Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche
IT1397246B1 (it) 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
IT1397247B1 (it) 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi agenti regolatori dell'attivita' citochinica
US20130209531A1 (en) 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
WO2012129461A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
US10849914B2 (en) 2017-06-12 2020-12-01 University Of Utah Research Foundation Methods for producing chemoembolic agents for the delivery of anti-cancer agents
KR102248721B1 (ko) 2018-09-13 2021-05-07 주식회사 엘지화학 황산화 히알루론산 기반의 하이드로겔 및 이를 포함하는 약제학적 조성물
KR20200055645A (ko) * 2019-08-08 2020-05-21 고려대학교 산학협력단 황산화된 히알루론산 유도체, 이의 제조방법 및 이를 포함하는 근골격계 관절질환의 예방 또는 치료용 약학 조성물
WO2021133000A1 (ko) * 2019-12-23 2021-07-01 주식회사 엘지화학 항염 또는 항혈관신생용 약제학적 조성물
IT202000032243A1 (it) 2020-12-23 2022-06-23 Fidia Farm Spa Nuovi agenti antivirali

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
ATE129254T1 (de) * 1987-03-19 1995-11-15 Arthropharm Pty Ltd Antientzündungsmittel und zusammensetzungen.
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
DE4021066A1 (de) * 1990-07-03 1992-01-09 Hoechst Ag Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
AU1154992A (en) * 1991-01-30 1992-09-07 Hoechst Aktiengesellschaft Use of substituted polysaccharides for the treatment of degenerative articular ailments
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
WO1996024362A1 (fr) * 1995-02-07 1996-08-15 Shiseido Company, Ltd. Agents anti-inflammatoires
US5922742A (en) * 1996-04-23 1999-07-13 Merck Frosst Canada Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
US6579978B1 (en) * 1997-04-04 2003-06-17 Fidia Farmaceuti S.P.A. Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
JPH11269077A (ja) * 1998-03-19 1999-10-05 Maruho Co Ltd ホスホリパーゼａ２阻害用医薬組成物
WO2000056298A2 (en) * 1999-03-19 2000-09-28 Luitpold Pharmaceuticals, Inc. Treatment of lyme disease with polysulfated glycosaminoglycan formulations
WO2000069917A1 (fr) * 1999-05-18 2000-11-23 Maruho Kabushikikaisha Compositions medicinales destinees a inhiber le systeme kallikreine-kinine ou la phospholipase a¿2?

Also Published As

Publication number Publication date
AU2152802A (en) 2002-04-29
JP2004531460A (ja) 2004-10-14
CY1106479T1 (el) 2012-01-25
HK1062524A1 (en) 2004-11-12
AU2002221528B2 (en) 2007-03-22
PT1385492E (pt) 2007-06-29
DE50112247D1 (de) 2007-05-03
DE10053053A1 (de) 2002-05-16
WO2002032407A2 (de) 2002-04-25
US20040053885A1 (en) 2004-03-18
CA2426083A1 (en) 2003-04-16
ES2284714T3 (es) 2007-11-16
WO2002032407A3 (de) 2003-11-20
US20070054878A1 (en) 2007-03-08
EP1385492A2 (de) 2004-02-04
EP1385492B1 (de) 2007-03-21
ATE357224T1 (de) 2007-04-15

Similar Documents

Publication Publication Date Title
DK1385492T3 (da) Anvendelse af hyaluronsyre-derivater til inhibering af inflammatorisk arthritis
AR039688A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
DK0975367T3 (da) Forbedret afgivelse af lægemidler til slimhindeoverflader
AR052153A1 (es) Composiciones y metodos para la estabilizacion de ingredientes farmaceuticos activos
JP2004531460A5 (ja)
EP2289523A3 (en) Regimens for intra-articular viscosupplementation
SV2006002165A (es) Regimenes y kits de progestina ciclica ref. am101677
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
AR037260A1 (es) Formulaciones de proteinas de liberacion sostenida acuosas
DE60103627D1 (de) SELBSTEMULGIERENDES ARZNEISTOFFVERABREICHUNGSSYSTEM, wobei das Fettmittel optional ist
AR044050A1 (es) Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos
ATE541562T1 (de) Ibuprofen-suspension
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
RS20050662A (en) Liquid formulations of tumor necrosis factor-binding proteins
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
AR022462A1 (es) Uso de un agente que disminuye el colesterol
Smith et al. A role for histamine in cytokine modulation by the adenosine A3 receptor agonist, 2-Cl-IB-MECA
DK1227826T3 (da) Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf
BR0007513A (pt) Fosfatidilinositóis sulfatados, sua preparação euso
HRP20070081T5 (en) Nasal pharmaceutical composition of piribedil
BR0009778A (pt) Composições antifúngicas de pseudomicina e métodos para utilização das mesmas
BR112022008192A2 (pt) Queratina bd-4, sua preparação e composições farmacêuticas e uso
EA200501765A2 (ru) Средство для лечения болезней суставов
MX2021006317A (es) Formulaciones farmaceuticas de base acuosa de compuestos de 1,2-dihidropiridina.